BRIEF-Mateon Therapeutics Inc Says First Patient Enrolled This Week In Its Phase IV Study
BRIEF-Mateon Therapeutics Inc Says First Patient Enrolled This Week In Its Phase IV Study
Brief-Mateon治療公司表示,本週第一名患者登記參加其IV期研究
Oct 7 (Reuters) - Mateon Therapeutics Inc MATN.PK :
路透10月7日電-Mateon治療公司MATN.PK:
* MATEON THERAPEUTICS INC - ANNOUNCED FIRST PATIENT ENROLLED THIS WEEK IN ITS PHASE IV STUDY ARTI-19
*MATEON治療公司-本週宣佈第一名患者參加其第四階段研究ARTI-19
* MATEON THERAPEUTICS INC - TOP-LINE DATA FROM ARTI-19 IS EXPECTED BY END OF 4Q20
*MATEON治療公司-ARTI-19的一線數據預計將在20年第四季度末公佈
Source text for Eikon: Further company coverage:
Eikon的源文本:進一步的公司報道: